NotizieBenzingaNovo Nordisk Announces New Retrospective Real-world Evidence For Type 2 Diabetes Showing Semaglutide Injection 2 Mg Was Associated With A Statistically Significant 6% Lower Risk Of Major Adverse Cardiovascular Events, Than Those Who Switched To... Novo Nordisk Announces New Retrospective Real-world Evidence For Type 2 Diabetes Showing Semaglutide Injection 2 Mg Was Associated With A Statistically Significant 6% Lower Risk Of Major Adverse Cardiovascular Events, Than Those Who Switched To... Benzinga 2026.09.29 10:35 (GMT+0) Apri Benzinga Altre notizie Morgan Stanley conferma il rating Overweight su Apple con domanda stabile per iPhone 18 La FDA concede lo status di Fast Track al farmaco di BeyondSpring per il tumore polmonare CIBC arranges un finanziamento per l’acquisizione di Orgvue 1-800-Flowers vende PersonalizationMall per 45 milioni di dollari Plug Power firma un accordo da 280 MW per un progetto in Danimarca NeurAxis nomina Craig Blanchard come Chief Commercial Officer
